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Abstract. 
 
The unfolded protein response (UPR) is an 
intracellular signaling pathway that relays signals from 
the lumen of the ER to activate target genes in the nu-
cleus. We devised a genetic screen in the yeast 
 
Saccha-
romyces cerevisiae
 
 to isolate mutants that are depen-
dent on activation of the pathway for viability. Using 
this strategy, we isolated mutants affecting various as-
pects of ER function, including protein translocation, 
folding, glycosylation, glycosylphosphatidylinositol 
modiﬁcation, and ER-associated protein degradation 
(ERAD). Extending results gleaned from the genetic 
studies, we demonstrate that the UPR regulates traf-
ﬁcking of proteins at the translocon to balance the 
needs of biosynthesis and ERAD. The approach also 
revealed connections of the UPR to other regulatory 
pathways. In particular, we identiﬁed 
 
SON1/RPN4
 
, a 
recently described transcriptional regulator for genes 
encoding subunits of the proteasome. Our genetic strat-
egy, therefore, offers a powerful means to provide in-
sight into the physiology of the UPR and to identify 
novel genes with roles in many aspects of secretory and 
membrane protein biogenesis.
Key words: protein translocation • protein matura-
tion • gene regulation • glycosylation • protein degra-
dation
 
Introduction
 
The segregation of specific functions into discrete com-
partments, or organelles, is a hallmark of all eukaryotic
cells. As such, maintenance of organelles and their activi-
ties are under precise regulatory control (Nunnari and
Walter, 1996). Until recently, little was known regarding
the mechanisms used to monitor and respond to a cell’s
needs for specific organelle functions. Early clues came
from observations of a regulatory pathway in mammalian
cells whereby two genes, 
 
GRP78
 
 (BiP) and 
 
GRP94
 
, are in-
duced by N-linked glycosylation inhibitors or glucose dep-
rivation (Pouyssegur et al., 1977). Since these perturba-
tions affect functions of the ER, it was suggested that gene
activation was a consequence of ER stress. This notion
was demonstrated directly through the expression of pro-
tein folding defective mutants of the influenza HA glyco-
protein. In cells expressing such mutant proteins, 
 
GRP78
 
(BiP) transcription is induced specifically (Kozutsumi et
al., 1988). These early experiments established the exist-
ence of a signal transduction pathway between the ER and
nucleus, termed the unfolded protein response (UPR)
 
1
 
(Mori et al., 1992).
The UPR is a ubiquitous mechanism observed in all eu-
karyotic organisms from humans to yeast (reviewed in
Chapman et al., 1998; Kaufman, 1999). An important step
in uncovering the mechanisms underlying the UPR came
from promoter studies of the known target gene, 
 
KAR2
 
.
Deletion analysis revealed specific promoter elements
termed UPREs (unfolded protein response elements) that
are required for regulated gene activation (Mori et al.,
1992; Kohno et al., 1993). The UPRE defined from yeast
 
KAR2
 
 when combined with the 
 
CYC1
 
 TATA box is suffi-
cient to drive the UPR-dependent expression of a heterol-
ogous reporter gene. This result was key to a genetic strat-
egy for isolating mutants defective for signaling through
the UPR (Cox et al., 1993; Mori et al., 1993). The first gene
identified encodes an ER transmembrane protein with a
cytosol-facing serine/threonine kinase, Ire1p (also termed
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,
protein processing in the ER gene; UPR, unfolded protein response;
UPRE, unfolded protein response element. 
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Ern1p), which acts as a sensor of the ER lumen. Through
an unknown mechanism, stimuli such as accumulation of
misfolded proteins cause Ire1p to oligomerize and trans-
autophosphorylate as a prerequisite step for activation
(Shamu and Walter, 1996). Hereafter, the mechanism of
signal transduction diverges radically from paradigms de-
rived from studies of plasma membrane receptors. Upon
activation, a cytosolic nuclease domain of Ire1p excises an
intron from 
 
HAC1
 
 mRNA (Cox and Walter, 1996; Kawa-
hara et al., 1997), which encodes a UPRE-specific tran-
scription activator (Cox and Walter, 1996; Mori et al.,
1996). tRNA ligase then joins the two exons, thereby
completing the splicing of 
 
HAC1
 
 mRNA by a noncon-
ventional, nonspliceosomal mechanism (Sidrauski et al.,
1996). Unspliced
 
 HAC1
 
 mRNA is stable in cells and ini-
tiates translation, but the presence of the intron stalls ribo-
somes so that no Hac1p is produced (Chapman and
Walter, 1997). Removal of the intron upon UPR activa-
tion relieves the translational block to allow synthesis of
Hac1p and the induction of target genes; the Ire1p-medi-
ated splicing reaction, therefore, is a key regulatory step in
the pathway.
Despite the detailed understanding of the mechanisms
surrounding UPR signaling and gene regulation, the pre-
cise physiological role of the pathway has remained largely
unexplored. The most extensive list of targets was assem-
bled from yeast and includes
 
 KAR2
 
, 
 
LHS1
 
, 
 
FKB2
 
, 
 
PDI1
 
,
 
EUG1
 
, and 
 
ERO1
 
. The products of these genes localize to
the ER lumen and catalyze protein folding. 
 
KAR2
 
 and
 
LHS1
 
 encode proteins with similarity to the Hsp70 class of
molecular chaperones (Normington et al., 1989; Rose et
al., 1989; Craven et al., 1996). 
 
FKB2
 
 is a prolyl isomerase
homologue (Partaledis and Berlin, 1993). 
 
PDI1
 
, 
 
EUG1
 
,
and 
 
ERO1
 
 promote disulfide bond formation (LaMantia
et al., 1991; Tachibana and Stevens, 1992; Craven et al.,
1996; Pollard et al., 1998). Thus, the UPR regulates the
abundance of ER resident chaperones and other enzymes
required for folding, assembly, and modification of secre-
tory and membrane proteins.
The initial identification of 
 
IRE1
 
 as a component of
UPR signaling provided additional clues. 
 
IRE1
 
 was first
reported as a gene required for inositol prototrophy (Ni-
kawa and Yamashita, 1992). It was later found that regula-
tion of the inositol biosynthetic pathway requires a func-
tional UPR (Cox et al., 1997). The observation showed
that the inositol pathway interacts intimately with the
UPR. Since inositol biosynthesis and other aspects of lipid
biosynthesis are coregulated, these observations suggest
that the UPR is involved in the regulation of membrane
biosynthesis. Such a connection may serve to expand the
ER, when more ER resident proteins need to be accom-
modated as the result of UPR induction.
Proteins that enter the ER and cannot be folded cor-
rectly, even after boosting ER folding capacity through
UPR induction, are degraded. The degradation pathway,
termed ER-associated protein degradation (ERAD; re-
viewed in Sommer and Wolf, 1997; Brodsky and Mc-
Cracken, 1999), translocates misfolded proteins back into
the cytosol, where they are degraded by the proteasome.
Retrotranslocation (also called dislocation) is thought to
utilize the same core protein complex (Sec61p and associ-
ated subunits) that forms the protein conducting channel
 
in the translocon through which proteins are delivered to the
ER lumen. Conceptually, the UPR, in its previously known
scope, and ERAD provide different means of dealing with
protein misfolding in the ER: the UPR by inducing enzymes
thought to play a corrective role and ERAD to dispose of
proteins that cannot be rescued. Here, and in a concomitant
study (Travers et al., 2000), we show that the two pathways
indeed are intimately linked and that the scope of the UPR
encompasses many more aspects of protein maturation and
ER quality control than previously appreciated.
 
Materials and Methods
 
Strains and Antibodies
 
Yeast strains used in this study are described in Table I. Anticarboxypep-
tidase Y (anti-CPY) antiserum generously provided by Dr. Reid Gilmore
(University of Massachusetts, Worcester, MA). Anti-Gas1p antiserum
was a kind gift of Dr. Howard Riezman (University of Basel, Switzerland).
Anti-HA mAb (12CA5) was generated by Berkeley Antibody Company.
 
Plasmids Used in This Study
 
pCS15 (
 
SEC61, LEU2
 
) was provided by Dr. Randy Schekman (University
of California, Berkeley, CA) and pMR713 (
 
KAR2, LEU2
 
) was provided
by Dr. Mark Rose (Princeton University, Princeton, NJ).
 
Construction of pDN336 and pDN388.  
 
The plasmid pDN336 used as
the reporter in strain DNY421 was constructed by inserting the full-length
 
IRE1
 
 gene, released from pCS110 (Cox et al., 1993) as an XhoI/BamHI
fragment, and the full-length 
 
ADE3
 
 gene, released as a BamHI/NheI frag-
ment, into XhoI/XbaI sites of the yeast shuttle vector, pRS316 (
 
URA3
 
,
 
CEN6
 
, 
 
ARSH4
 
; Sikorski and Hieter, 1989). Both the XbaI and the NheI
sites were destroyed in the construction. pDN388 is similar, except that
the insert is in the pRS315 vector (
 
LEU2
 
, 
 
CEN6
 
, 
 
ARSH4
 
; Sikorski and
Heiter, 1989).
 
pDN390.  
 
The plasmid, pJC835, containing the 
 
HAC1
 
i
 
 gene in the shut-
tle vector, pRS313 (Cox and Walter, 1996), was digested with AlwNI and
NgoMI to release the gene. The fragment was ligated into pRS315 di-
gested with the same sites.
 
CPY*
 
HA
 
 Expression Vectors. 
 
The 
 
prc1-1
 
 allele expresses the variant
CPY* as a glycine to arginine change at position 255 (Finger et al., 1993).
We constructed an HA epitope-tagged version of CPY* by site-directed
mutagenesis using a PCR-based approach. The 
 
PRC1
 
 gene was first am-
plified as two fragments. The N-proximal fragment amplified with the
primers 5
 
9
 
-CCATCGAATTCCGTATAT-3
 
9
 
 and the phosphorylated
primer 5
 
9
 
-GAAATCTTGGCCCTTGTTGACG-3
 
9 
 
using Vent polymer-
ase (New England Biolabs). This fragment includes the 
 
PRC1
 
 promoter
and coding sequences to amino acid position 251. C-proximal sequences
were amplified using the phosphorylated primer 5
 
9
 
-CACATCGCTA-
GAGAATCCTACGCC-3
 
9
 
 incorporating a glycine to arginine change at
amino acid 251 and the primer 5
 
9
 
-CCCTCTAGACTAACCCAAAG-
AAGCGTAATCTGGAACATCATATGGGTATAAGGAGAAACC-
ACCG-3
 
9
 
, fusing the HA epitope tag, a termination codon, and an XbaI
site. The C-proximal fragment was amplified using Taq polymerase since
the primer combination precluded amplification by Vent polymerase un-
der all conditions attempted. Blunt ends were generated for this fragment
using T4 DNA polymerase. The N-proximal fragment was digested with
EcoRI, the C-proximal with XbaI, and both fragments ligated into the
vector pDN201 (Ng et al., 1996) digested with same enzymes. The mutant
gene in pDN431 was confirmed by DNA sequence analysis. A second ver-
sion of the plasmid, pDN436, was constructed by releasing the CPY*
 
HA
 
gene from pDN431 as a SalI/EcoRI (blunt) fragment and ligation into the
SalI/SmaI sites of pRS315 (Sikorski and Hieter, 1989).
 
Genetic Screen
 
The reporter strain for the screen was constructed by first crossing JC147
and EY0060. Diploids derived were sporulated, tetrads dissected, and
haploids screened for the following genotype: 
 
MAT
 
a
 
, 
 
ire1::TRP1
 
,
 
 ade2
 
,
 
ade3
 
, 
 
UPRE-LacZ::HIS3
 
. One such strain was isolated and transformed
with pDN336 to create DNY421.
For mutagenesis, 50 A
 
600
 
 OD units of DNY421 cells were washed once 
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in sterile water and resuspended in 25 ml 0.9% KCl. With constant stir-
ring, the cells were given four 30-s pulses of short wave UV light from a
source mounted 15 cm above. After each pulse, an aliquot was removed, a
portion serially diluted, and spread onto YPD plates to determine the kill
rate. The remainder of each aliquot was pelleted and resuspended in 10 ml
YPD media and allowed to recover for 18 h on a roller drum. All proce-
dures to this point were performed in a darkroom and incubations at 30
 
8
 
C.
Cells receiving a UV dose of 120 s resulted in a kill rate of 62% and were
used for the screen. Mutagenized cells were spread onto YPD plates lack-
ing additional adenine. Nonsectoring colonies were picked and rescreened
by restreaking for single colonies (see Results for specific numbers). Iso-
lates were backcrossed to DNY420 and recessive mutants determined by
the restoration of the colony sectoring phenotype of their respective het-
erozygote diploids. Tetrad dissection was performed to determine the al-
lelic complexity of the mutants. Only those exhibiting a 2:2 segregation
pattern indicating a single mutant gene were continued. All strains were
backcrossed at least twofold before further analysis.
Complementation tests were performed to determine the number of
genes represented in the initial group of 20. Complementing strains were
scored as those giving rise to colony sectoring diploids. However, before
the completion of all possible crosses, many strain combinations gave rise
to nonsectoring diploids indicating noncomplementation and therefore
suggesting different alleles of the same gene. Upon tetrad analysis of the
diploids, it was determined that, in most cases, mutant alleles were un-
linked. The criterion for linkage was 4:0 segregation of mutant to wild-
type spores. Tetrad analysis was performed for all possible crosses for the
assignment of linkage groups.
 
Cloning and Identification of PER Genes
 
Two general approaches were employed to clone 
 
PER
 
 (protein processing
in the ER) genes. The first takes advantage of the counterselectable
marker, 
 
URA3
 
, contained in the pDN336 (Boeke et al., 1984). Since the
growth of 
 
per
 
 mutants are dependent on the 
 
IRE1
 
, cells losing pDN336
fail to grow on media containing 5-fluoroorotic acid (5-FOA). Comple-
mentation of mutant alleles alleviates the requirement for 
 
IRE1
 
 and thus
allows for selection of complementing plasmids from genomic libraries.
The 
 
PER5
 
 and 
 
PER8
 
 genes were cloned using this first approach.
Mutant cells were transformed with a yeast genomic library based on
the multicopy YEp13 vector (Lagosky et al., 1987). After transformation,
the cells were grown overnight in SC-Leu media allowing transformants
receiving complementing plasmids to lose pDN336. Transformants were
later plated and incubated on SC-Leu media containing 5-FOA (1 mg/ml)
at 30
 
8
 
C. Plasmids were recovered from 5-FOA resistant isolates by zirco-
nium bead disruption and purification using the Wizard Miniprep kit
(Promega). Plasmid amplification was performed after transformation
into bacterial DH5
 
a
 
 cells. Retransformation of the recovered plasmids
into the respective mutant strains was typically carried out to assess
complementation of the sectoring phenotypes. Although this approach
worked well for 
 
PER5
 
 and 
 
PER8
 
, it was less successful for other strains
attempted. The high incidence of false positives due to plasmids carrying
truncated 
 
IRE1
 
 contained in the library added an additional layer to the
procedure that was overly time consuming.
The second approach scored for complementation of the sectoring phe-
notype using a low copy genomic library (used for cloning of 
 
PER2
 
,
 
PER4
 
, 
 
PER13
 
, and 
 
PER16
 
). The library, based on YCp50 (Rose et al.,
1987), required that the reporter pDN336 be swapped for pDN388 to be
compatible. Mutant strains transformed by the library were spread onto
SC-Ura/adenine-limiting (6 
 
m
 
g/ml) plates at low density (400 cfu/plate) to
develop the colony color phenotype. Typically, between 10,000 and 25,000
transformants were screened for restoration of sectoring. Positives were
cured of the reporter and complementing plasmids were recovered as de-
scribed above. Recovered plasmids were transformed back into the re-
spective mutant strains to confirm complementation.
 
Table I. Strains Used in This Study
 
Strain Genotype Source
 
W303a
 
MAT
 
a
 
, 
 
leu2-3-112, his3-11, trp1-1, ura3-1, can1-100, ade2-1
 
Walter lab 
EY0060
 
MAT
 
a
 
, 
 
ade3
 
, W303 background Erin O’Shea, UCSF
JC147
 
MAT
 
a
 
, 
 
ire1::TRP1
 
,
 
 ura3-1, can1-100, ade2-1, leu2-3-112::LEU2-UPRE LacZ, his3-11::HIS3-UPRE LacZ
 
Cox et al.
 
,
 
 1993
JC408
 
MAT
 
a
 
, 
 
hac1::URA3,
 
 
 
trp1-1, his3-11,-15, ade2-1,
 
 
 
leu2-3-112::LEU2-UPRE LacZ
 
Walter lab 
JC409
 
MAT
 
a
 
, JC408 background Walter lab 
DNY70
 
MAT
 
a
 
, 
 
sec62-101, ura3
 
D
 
99, leu2
 
D
 
1, trp1
 
D
 
99, ade2-101
 
ochre
 
Ng et al.
 
,
 
 1996
DNY420
 
MAT
 
a
 
, 
 
ire1::TRP1
 
,
 
 ura3-1, can1-100, ade2-1, ade3, leu2-3-112::LEU2-UPRE LacZ, his3-11::HIS3-UPRE LacZ
 
, (pDN336) This study
DNY421
 
MAT
 
a
 
, 
 
ire1::TRP1
 
,
 
 ura3-1, can1-100, ade2-1, ade3, leu2-3-112,
 
 
 
his3-11::HIS3-UPRE LacZ, 
 
(pDN336) This study
DNY486
 
MAT
 
a
 
, 
 
per1-1
 
, DNY421 background This study
DNY499
 
MAT
 
a
 
, 
 
per1-2
 
, DNY421 background This study
DNY489
 
MAT
 
a
 
, 
 
per2-1
 
, DNY421 background This study
DNY491
 
MAT
 
a
 
, 
 
per3-1
 
, DNY421 background This study
DNY493
 
MAT
 
a
 
, 
 
per4-1
 
, DNY421 background This study
DNY478
 
MAT
 
a
 
, 
 
per4-2
 
, DNY421 background This study
DNY495
 
MAT
 
a
 
, 
 
per5-1, DNY421 background This study
DNY497 MATa, per6-1, DNY421 background This study
DNY503 MATa, per6-2, DNY421 background This study
DNY501 MATa, per7-1, DNY421 background This study
DNY505 MATa, per8-1, DNY421 background This study
DNY507 MATa, per9-1, DNY421 background This study
DNY509 MATa, per10-1, DNY421 background This study
DNY484 MATa, per10-2, DNY421 background This study
DNY488 MATa, per11-1, DNY421 background This study
DNY470 MATa, per12-1, DNY421 background This study
DNY472 MATa, per13-1, DNY421 background This study
DNY475 MATa, per14-1, DNY421 background This study
DNY479 MATa, per15-1, DNY421 background This study
DNY481 MATa, per16-1, DNY421 background This study
DNY523 MATa, per1-1, W303 background This study
DNY540 MATa, per15-1, W303 background This study
DNY563 MATa, pDN431, W303 background This study
DNY572 MATa, cue1::TRP1, pDN431, W303 background This study
ESY157 MATa, ire1::TRP1, pDN431, W303 background This study
ESY158 ESY157 with pMR713 (KAR2) This study
ESY159 ESY157 with pCS15 (SEC61) This studyThe Journal of Cell Biology, Volume 150, 2000 80
For all clones, DNA sequence analysis was performed to determine the
identity of inserts (Nucleic Acid Facility, Pennsylvania State University,
University Park, PA). The sequences of vector/insert junctions were ob-
tained using the primers N168 (59-CGCTACTTGGAGCCACTATC-
GAC-39) and N169 (59-ATCGGTGATGTCGGCGATAT-39). Junction
sequences were submitted to the Saccharomyces Genome Database (http:
//genome-www.stanford.edu/Saccharomyces/) to obtain complete insert
sequences and identities of open reading frames. The insert sequences
were used to facilitate deletion mapping using standard recombinant
DNA methods to determine specific complementing genes. Subclones of
genes derived from the high copy library (YEp13) were inserted into cen-
troplasmic plasmids to assess complementation.
Cell Labeling and Immunoprecipitation
Typically, 3 A600 OD units of log phase cells were pelleted and resus-
pended in 0.9 ml of SC media lacking methionine and cysteine. After 30
min of incubation at the appropriate temperature, 150 mCi of [35S]Met/
Cys (Pro-mix; Amersham Pharmacia Biotech) is added to cells for 5 or 10
min. A chase, where appropriate, was initiated by adding cold methionine/
cysteine to a final concentration of 2 mM. Cell labeling/chase was termi-
nated by the addition of trichloroacetic acid to 10%. Cells were homoge-
nized by the addition of 0.4 ml of 0.5-mm zirconium beads, followed with
agitation in a Mini-bead beater cell disrupter (Biospec Products). The ho-
mogenate was transferred to a fresh tube and pooled with a subsequent
10% TCA bead wash. After centrifugation, the TCA precipitate pellet
was resuspended in 120 ml of IPS II (100 mM Tris base, 3% SDS, 1 mM
PMSF) and heated to 1008C for 5 min. Insoluble debris was pelleted and
40 ml of the detergent lysate was added to 560 ml IPS II (1% Triton X-100,
50 mM Tris, pH 7.5, 1 mM PMSF, 1 ml yeast protease inhibitor cocktail;
Sigma-Aldrich) and the appropriate antiserum. After a 2-h incubation at
48C, the sample was centrifuged for 10 min at 16,000 g and the supernatant
transferred to a fresh tube containing protein A–Sepharose beads. The
tube was rotated for 30 min and washed three to five times with IPS I
(0.2% SDS, 1% Triton X-100, 50 mM Tris, pH 7.5) and once with PBS.
Immunoprecipitated proteins were eluted with gel sample buffer, sepa-
rated by gel electrophoresis, and visualized by autoradiography.
In pulse-chase assays to determine protein stability, immunoprecipita-
tions were normalized by measuring TCA-precipitable counts using an
LS5801 scintillation counter (Beckman Coulter) and adjusting lysates for
equal counts.
Northern Blot Analysis
Preparation of RNA, gel electrophoresis, blot transfer, and probing were
performed as described in Cox and Walter (1996). RNA from UPR-
induced cells were treated for 60 min with 2.5 mg/ml tunicamycin (Sigma-
Aldrich) before RNA isolation. All templates for probes were prepared
by PCR amplification of genomic DNA. Probes were prepared by random
primer extension labeling using [32P]a-dCTP. The ACT1 template is a
600-bp fragment corresponding to the 39-end of coding sequences. The
KAR2 template is a 600-bp fragment corresponding to the 59-end of cod-
ing sequences. Two RFT1 templates were prepared and used indepen-
dently. One includes 600 bp of the 59-coding sequences and the other in-
cludes 700 bp of the 39-coding sequences.
Results
Genetic Screen
We devised two complementary approaches to identify in
an unbiased way cell functions that are regulated by or are
dependent on the UPR. First, we used whole genome mi-
croarray analysis to directly identify UPR target genes
(Travers et al., 2000). This approach allowed us to define
the transcriptional scope of the UPR. Second, we devised
the genetic screen that is described here in which we iso-
lated mutants that are dependent on UPR activation for
viability. This second approach aims to highlight physio-
logically relevant functions that connect with the UPR.
The feasibility of this approach was suggested by the ob-
servations that genes mediating the UPR are nonessential
(Cox et al., 1993; Mori et al., 1993), yet display synthetic
lethality (that is, cell inviability caused by the combination
of two nonlethal mutations) with two known target genes
(KAR2 and LHS1; Craven et al., 1996; Sidrauski et al.,
1996). In both kar2 and lhs1 mutants, the UPR is constitu-
tively activated, which must allow the cell to compensate
for the loss of the function of these genes. In principle, ge-
netic and microarray analyses should be complementary,
as some functions that are dependent on or affected by
UPR activation may not be transcriptional targets of the
pathway.
We performed the screen using a yeast colony color sec-
toring assay (Koshland et al., 1985). Yeast cells harboring
an ade2 mutation give rise to red colonies when grown on
media limiting for adenine. If a strain contains both mu-
tant ade2 and ade3 alleles, the red pigment is not synthe-
sized, and colonies are white. We constructed an ade2 ade3
mutant strain that is deleted for IRE1 (DNY421, Table I).
This strain grows well on rich media. In addition, we con-
structed a centromeric reporter plasmid, pDN336, con-
taining IRE1 and ADE3, which was transformed into
DNY421 cells. Since ADE3 and IRE1 are not essential,
the plasmid is lost at a frequency of z1022 per cell division
(Guthrie and Fink, 1991). For this reason, DNY421 cells
gives rise to red and white sectored colonies, reflecting a
mixed population of cells with and without the plasmid.
Because IRE1 is required for activation of the UPR path-
way, mutants that require UPR activation for growth can-
not lose the IRE1-bearing plasmid and hence, are ex-
pected to give rise to red nonsectored colonies.
DNY421 cells were mutagenized with ultraviolet light to
62% lethality. We screened z50,000 colonies and isolated
101 nonsectoring and normally growing colonies. Of these,
40 were backcrossed to the parental strain, yielding 32 re-
cessive, 2 dominant, and 6 sterile isolates. The dominant
and sterile mutants were discarded. Heterozygous diploids
generated from recessive mutants were sporulated and
subjected to tetrad analysis to determine the segregation
patterns. Of the diploids, 25 were sporulation-competent.
Of those, 15 segregated 2:2 with a synthetic lethal pheno-
type and 5 with a synthetic negative growth phenotype
(spores containing both mutations were viable, but dis-
played severely reduced growth rates), indicative of a sin-
gle gene being responsible for the mutant phenotype. Of
the remaining mutants, five exhibited other patterns and
were discarded.
When crossed to each other, many of the mutants exhib-
ited partial sectoring phenotypes that precluded clear de-
termination of complementation. This was not a general
effect of ploidy since all 20 mutants, when crossed to the
parental strain, formed sectored colonies unambiguously.
Further analysis demonstrated that most mutant genes are
unlinked. These observations suggest some combinations
of mutations display the genetic interaction termed un-
linked noncomplementation. Although the significance for
this group remains to be determined, unlinked noncom-
plementation has been used to help identify genes of the
same function or pathway (Stearns and Botstein, 1988). To
group the 20 mutants, we crossed individual mutant strains
and systematically subjected the resulting diploids to tet-
rad analysis. Most crosses failed to display linkage be-
tween the mutant alleles, indicating that the mutationsNg et al. Role of the Unfolded Protein Response Pathway 81
were in different genes. This analysis defined 16 linkage
groups indicating at least as many genes (Table II). We re-
fer to the genes defined by the mutants as PER (protein
processing in the ER) because most mutant alleles can be
shown to affect various aspects of ER protein biogenesis
and quality control (see below). The high fraction of per
mutants represented by a single allele indicates that the
screen is far from saturated.
To establish PER mutants as tools to study the func-
tional role of the UPR, we next assessed their physiologi-
cal relevance. To this end, we required two criteria to be
met: activation of the UPR pathway should alleviate the
synthetic growth defect caused by the mutation, and the
mutants should exhibit a constitutive activation of the UPR.
To address the first criterion, we activated the UPR consti-
tutively by expression of the Hac1p transcriptional activa-
tor (Cox and Walter, 1996). We constructed a plasmid,
pDN390, carrying HAC1i ( HAC1 deleted of its intron)
and transformed it into each per mutant (Dire1 cells cov-
ered by pDN336 bearing wild-type IRE1). Cells were then
scored for improved growth after loss of pDN336, ob-
tained by screening for white, nonsectoring colonies. Us-
ing these criteria, all but two mutants (per1-1 and per15-1)
could be relieved of the requirement for IRE1 function by
directly activating the pathway (Table II). After crosses of
the two remaining mutants (DNY523 and DNY540) with
Dhac1 cells were sporulated, however, tetrad analysis re-
vealed clear synthetic negative phenotypes for both mu-
tants (data not shown). Thus, taken together, the results
indicate that the synthetic defect of all 16 per mutants is
due to the loss of the UPR pathway, rather than to the loss
of a yet uncharacterized function of IRE1 unrelated to
UPR signaling.
To address the second criterion for physiological rele-
vance, we determined the extent of constitutive UPR acti-
vation in mutant cells. The parental strain (DNY421) used
in this study contains a genomic copy of a lacZ reporter
gene fused to a minimal UPR promoter (Cox et al., 1993).
Thus, b-galactosidase activity can be used to monitor
activation of the pathway. Mutant cells were grown to
early log phase, and cell extracts were prepared to mea-
sure b-galactosidase activity with the substrate 2-nitrophe-
nyl-b-D-galactopyranoside (Cox et al., 1993). As shown in
Fig. 1, with the exception of per16-1, all per mutants ex-
press b-galactosidase activity above wild-type levels, indi-
cating induction of the UPR. Interestingly, the degree of
UPR induction among the mutants varies widely, indicat-
ing that the UPR can be gradually modulated depending
on the physiological needs of the cell.
Functions of PER Genes
Having satisfied the criteria for a physiological relation-
ship, we next assessed functional defects of per mutants.
To this end, we first monitored the processing and trans-
port of the membrane protein Gas1p (Nuoffer et al.,
1991). Because Gas1p undergoes a variety of posttransla-
tional modifications during its biogenesis, defects at any
stage can be detected by changes in gel mobility. Gas1p is
initially synthesized in the cytosol as a 60-kD precursor
that is detectable in protein translocation mutants (Ng et
al., 1996). Upon entry into the ER, it is modified by N- and
O-linked glycosylation, as well as by addition of a glyco-
sylphosphatidylinositol (GPI) membrane anchor shifting
its apparent molecular weight to 110 kD (Nuoffer et al.,
1991). Gas1p folding occurs in the ER and requires the
formation of intramolecular disulfide bonds (Frand and
Kaiser, 1998). Only after correct folding can Gas1p con-
tinue to the Golgi apparatus (t1/2 , 10 min), where carbo-
hydrate modification further changes its gel mobility to
Table II. Summary of per Mutant Characterization
Allele Gene Temperature conditional phenotype Interaction with Dire Protein processing defect Suppressing by Hac1ip
per1-1 ts SN Gas1p No
per1-2 SN Yes
per2-1 MCD4‡ ts SL Gas1p Yes
per3-1 SL Glycosylation Yes
per4-1 LHS1‡ SL Yes
per4-2 LHS1‡ cs SL Yes
per5-1 RFT1‡ SL Glycosylation Yes
per6-1 SL Glycosylation Yes
per6-2 ts SL Glycosylation Yes
per7-1 SL CPY*HA degradation Yes
per8-1 SON1 cs SL CPY*HA degradation Yes
per9-1 SL Gas1p/CPY*HA degradation Yes
per10-1 SL Yes
per10-2 SL Yes
per11-1 SN Yes
per12-1 ts SL Glycosylation Yes
per13-1 GPI10 ts SN Gas1p/CPY*HA degradation Yes
per14-1 SL Glycosylation Yes
per15-1 ts/cs SL Gas1p No
per16-1 UBC7‡ SN CPY*HA degradation Yes
per mutant allele designations listed with corresponding gene names, if known. ts, Temperature-sensitive: impaired or no growth at 378C; cs, cold-sensitive: impaired or no growth
at 168C; SL, synthetic lethal: mutation is lethal in combination with Dire1, as determined by tetrad analysis; SN, synthetically negative: mutation causes severely impaired growth
in combination with Dire1, as determined by tetrad analysis.
‡Denotes genes as UPR-inducible, determined by Northern analysis or genomic microarray analysis (Travers et al.,2000).The Journal of Cell Biology, Volume 150, 2000 82
125 kD (Nuoffer et al., 1991). Thus, defects in a variety of
ER functions can be detected by monitoring Gas1p pro-
cessing.
Wild-type (W303) and per mutant cells were metaboli-
cally pulse-labeled with [35S]amino acids for five minutes
and chased with an excess of unlabeled methionine and
cysteine for 30 min to allow for full processing of Gas1p
(Fig. 2 A, lanes 2–22). As shown in Fig. 2, no preGas1p
was observed in any lane, indicating that none of the per
mutants displayed severe defects in protein translocation.
However, about half of the mutants are defective in pro-
cessing to the mature 125 kD form. These results indi-
cate defects in ER protein processing functions that may
include glycosylation, folding, GPI-anchor addition, or trans-
port.
To distinguish the molecular nature of the observed de-
fects further, we monitored the processing of another pro-
tein, the vacuolar protease CPY (Simons et al., 1995). The
ER form of CPY is a core glycosylated proform (P1; Fig. 2
B, lane 1). The P1 form of CPY is transported to the Golgi
apparatus, where it is modified by outer chain glycosyla-
tion to the P2 form. ProCPY is ultimately proteolytically
processed to the mature form after transport to the vacu-
ole (Fig. 2 B, lane 2). Underglycosylated CPY remains
competent for folding and transport to the Golgi appara-
tus and vacuole. In the vacuole, it is processed to charac-
teristic forms designated -1, -2, -3, -4 (te Heesen et al.,
1992). Thus, based on specific gel mobility patterns, mu-
tants defective for N-linked glycosylation can be easily dis-
tinguished.
As shown in Fig. 2 B, mutants per3-1, per5-1, per6-1,
per6-2, per12-1, and per14-1 exhibited CPY underglyco-
slyation indicative of defective N-linked glycosylation. Cor-
respondingly, these mutants synthesized forms of Gas1p
with altered mobility expected for glycosylation mutants
(Fig. 2 A). The size of the underglycosylated forms indi-
cates that most of CPY is proteolytically processed to the
mature form in each of the mutants, indicating that these
mutants are not generally defective in protein transport
from the ER to the Golgi apparatus.
The PER5/RFT1 Gene Is a Novel UPR Target Required 
for N-linked Glycosylation
We chose to analyze per5-1 in greater detail because it ex-
hibited the most severe glycosylation defect. To this end,
we analyzed CPY by pulse-chase analysis, followed by en-
Figure 1. per mutants activate the unfolded protein response
pathway. Wild-type and mutant cells carrying the UPRE-LacZ
reporter gene are grown logarithmically and lysed. b-galacto-
sidase activity is measured from lysates using 2-nitrophenyl-
b-D-galactopyranoside (ONPG) as substrate and detected as an
increase in absorbance at 420 nM. TM, cells treated with 2.5 mg/
ml tunicamycin for 60 min before lysis.
Figure 2. Processing of
Gas1p and CPY in per mu-
tants. Logarithmically grow-
ing wild-type and mutant cells
were metabolically labeled
with [35S]methionine/cys-
teine for 5 min at 308C, fol-
lowed by a chase for 30 min.
From detergent lysates,
Gas1p and CPY were immu-
noprecipitated using mono-
specific polyclonal antisera.
As a control, these proteins
were also immunoprecipi-
tated from wild-type lysates
pulse-labeled with no chase
to indicate the ER forms
(lane 1). Proteins are sepa-
rated on a 10–15% polyacryl-
amide gradient gel and visual-
ized by fluorography. The
positions of preGas1p, ER Gas1p, and Golgi/plasma membrane Gas1p (Golgi/PM) are indicated (A). For CPY, the ER (P1), Golgi ap-
paratus (P2), and mature vacuolar form (CPY) are indicated to the left and the vacuolar underglycosylated forms (-1, -2, -3, -4) to the
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doglycosidase H digestion in wild-type and per5-1 cells. As
shown in Fig. 3 A, proCPY recovered after the pulse mi-
grated as multiple species with altered mobility in per5-1
cells as compared with the P1 species from wild-type cells
(Fig. 3 A, compare lanes 1 and 4). Removal of the sugar
chains revealed that the heterogeneity was exclusively due
to differences in glycosylation, as the deglycosylated forms
comigrated (Fig. 3 A, lanes 7–12). The kinetics of process-
ing to the mature form(s) was similar in both strains, indi-
cating that folding and transport functions are intact in
per5-1 cells. Similar results were obtained for Gas1p (Fig.
3 B), indicating that this defect is not substrate-specific.
To characterize the role of PER5 further, we cloned the
gene by complementation (see Materials and Methods). A
complementing plasmid, pDN386, was isolated from trans-
formed  per5-1 cells and portions of the insert further
subcloned to identify the complementing gene. Plasmid
pDN387, containing RFT1 as the only open reading frame,
fully complemented per5-1 as it restored the sectoring
phenotype and glycosylation function (Fig. 3 B). RFT1 is
an essential gene that encodes a predicted multispanning
transmembrane protein of unknown function (Koerte et
al., 1995). Thus, our approach identified PER5/RFT1 as a
novel gene required for N-linked glycosylation.
Inspection of the upstream sequences of PER5/RFT1
revealed a potential UPRE, suggesting that transcription
of PER5 is regulated by the UPR (Fig. 4 A). To address
this possibility directly, Northern analysis was performed
using RNA extracted from control cells and from cells
treated with the glycosylation inhibitor tunicamycin to in-
duce UPR-regulated genes. As shown in Fig. 4 B, PER5/
RFT1 is elevated in tunicamycin-treated cells (lanes 1–4).
Quantitative analysis showed a moderate 2.5-fold induc-
tion. This is in contrast to KAR2, which was induced over
8-fold (Fig. 4 B). Transcriptional regulation of PER5/RFT1,
as with KAR2, was dependent on the UPR, as no induc-
tion was detected in Dhac1 cells (Fig. 4 B, lanes 5 and 6).
Taken together, the analyses in Figs. 2–4 show that mu-
tations in at least 5 of 16 PER genes compromise impor-
tant functions in protein glycosylation and that genes of
heretofore unknown function have been identified in this
way. Moreover, these results reinforce the notion that the
UPR functions to regulate a variety of aspects of protein
biogenesis.
A Role for the UPR in ERAD
As many of the per mutants do not exhibit defects in
Gas1p or CPY maturation, we wondered whether other
aspects of ER function related to protein maturation
are affected in some of the per mutants. To test whether
Figure 3. A, per5-1 is defective in N-linked glycosylation. Wild-
type (W303a) and per5-1 cells were metabolically pulse-labeled
for 5 min and chased for 0, 15, and 30 min. CPY was immunopre-
cipitated from detergent lysates and divided into two aliquots for
each time point. One aliquot was treated with endoglycosidase H
and the other was mock-treated. Proteins were separated on a
10% polyacrylamide gel and visualized by fluorography. The po-
sitions of the different pro and mature glycoforms of CPY are in-
dicated as described in Fig. 2. Endo H deglycosylated pro (dg-
proCPY) and mature forms (dg-mCPY) are indicated to the
right. B, per5-1 is an allele of RFT1. Wild-type, per5-1, and per5-1
(pDN387) cells were pulse-labeled for 5 min and chased for 0 and
30 min. pDN387 is a centromeric vector containing the RFT1
gene. Immunoprecipitates of Gas1p were resolved by a 10–15%
polyacrylamide gradient gel and visualized by autoradiography.
The normal ER and mature (Golgi/PM) forms are shown.
Figure 4. PER5/RFT1 is a UPR target gene. A, Alignment of
UPRE sequences. Experimentally determined UPRE sequences
(Mori et al., 1998) are shown with an upstream sequence of
PER5/RFT1 that conforms to the palindromic motif shown by
the arrows. Dots denote additional important positions in the
motif. B, Northern analysis using RNA extracted from W303a,
DNY421, and Dhac1 cells incubated in the presence or absence of
2.5 mg/ml of tunicamycin for 60 min at 308C. PER5/RFT1, KAR2,
and ACT1 transcripts were blotted onto a nylon filter, hybridized
to  32P-labeled probes sequentially, and visualized by autora-
diography. Quantification was performed by PhosphorImager
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genes encoding ERAD components were identified in this
screen, we constructed a recombinant form of the ERAD
substrate, CPY* (Finger et al., 1993), modified by addition
of an HA epitope tag to simplify analysis. The new ver-
sion, designated CPY*HA, behaved as a proper ERAD
substrate: it was degraded rapidly in wild-type cells and
was stabilized in a strain lacking the ERAD gene, CUE1
(Fig. 5; Biederer et al., 1997). We transformed each of the
per mutants with pDN436, carrying the gene encoding
CPY*HA. Pulse-chase analysis was used to assess substrate
stability in each strain. Turnover of CPY*HA was delayed
in per7-1, per8-1, per9-1, per13-1, and per16-1 (Fig. 5). Two
mutants,  per9-1  and  per13-1, also displayed defects in
Gas1p processing, indicating that their defects are pleio-
tropic. Their ERAD phenotypes may therefore be indi-
rect. In all other per strains, including those displaying se-
verely impaired protein processing, the rate of CPY*HA
degradation was not altered (data not shown).
We next cloned some of the affected genes of per mu-
tants displaying ERAD defects, starting with PER8 and
PER16, which displayed defects similar in extent to the
Dcue1 strain. Plasmid pDN426 bearing SON1, completely
complemented the per8-1 mutant. Moreover, CPY*HA was
stabilized in Dson1 cells (data not shown), indicating that
the defect per8-1 cells reflects a loss-of-function. Son1p
was recently shown to be a transcription factor that regu-
lates proteasome biogenesis (Mannhaupt et al., 1999), and
Dson1 mutants are defective in cytosolic protein degrada-
tion (Johnson et al., 1995). Thus, a role for Son1p in
ERAD is quite plausible.
We cloned PER16 by screening for restoration of the
sectoring phenotype after a plasmid shuffle of the URA3-
marked reporter for LEU2 (pDN388) and transformation
of the library. Subcloning of the inserts of plasmids that re-
stored the sectoring phenotype of per16-1 cells identified
UBC7, which was sufficient to complement the per16-1
mutation. UBC7 encodes a ubiquitin-conjugating enzyme
that was previously shown to participate in ERAD (Bie-
derer et al., 1996; Hiller et al., 1996).
The isolation of ERAD mutants in this screen suggested
a tight physiological link between the UPR and ERAD.
We explored this notion further by monitoring the fate of
CPY*HA in a UPR-deficient strain. As shown in Fig. 6 A,
Figure 5. A subset of per mutants is defective for ERAD. All
twenty per mutants were transformed with pDN436 (CPY*HA)
and pulse-chase analysis performed to measure the degradation
of the ERAD substrate CPY*HA. Immunoprecipitates of
CPY*HA were normalized using TCA precipitable counts. The
proteins were separated by PAGE followed by autoradiography.
Quantification was performed by PhosphorImager analysis and
reported as percent remaining to the right of each respective au-
toradiogram. In addition to the wild-type (DNY563) and ERAD
mutant (DNY572, cue1::TRP1) controls, only per mutants with
significant ERAD defects are shown. Figure 6. The UPR is required for efficient ER protein transloca-
tion and ERAD. A, Wild-type and ire1::TRP1 cells (labeled
Dire1) expressing CPY*HA were pulse-labeled for 10 min with
[35S]methionine/cysteine and chased for 0, 30, 60, and 90 min.
CPY*HA was immunoprecipitated using anti-HA mAb and ana-
lyzed by SDS-PAGE. The proteins were visualized by direct au-
toradiography and quantification of the gel was performed using
a PhosphorImager. B, Wild-type, sec62-101, and Dire1 cells ex-
pressing CPY*HA were pulse-labeled for 10 min and CPY*HA im-
munoprecipitated and separated on a 10% polyacrylamide gel
(lanes 1, 2, and 3). Lanes 4 and 5, Gas1p immunoprecipitated
from the lysates used for lanes 1 and 3. C, Wild-type, sec62-101,
and Dire1cells expressing CPYHA were pulse-labeled for 10 min
and immunoprecipitated for endogenous CPY. The position of
preproCPYHA, the ER P1, and Golgi P2 forms are indicated.Ng et al. Role of the Unfolded Protein Response Pathway 85
CPY*HA was stabilized in Dire1 cells (Fig. 6 A, lanes 5–8),
whereas wild-type control cells degraded the substrate
rapidly. Surprisingly, we also observed the appearance of a
faster migrating band in Dire1 cells that was not detected
in control experiments performed with wild-type cells
(Fig. 6 A, labeled preproCPY*HA). Its mobility and the
timing of its appearance during the pulse suggested that
the band represents the cytoplasmic, nontranslocated
preproCPY*HA. To confirm this identity, we expressed
CPY*HA in sec62-101 cells, in which translocation of CPY
is severely impaired and thus accumulated cytosolic pre-
cursor proteins. The data in Fig. 6 B show that the pre-
proCPY bands comigrate (compare lanes 2 and 3).
These results raised the question whether impaired
translocation resulted from the synthesis of misfolded pro-
tein or from an increased flux of proteins through the ER
translocon due to ectopic expression of CPY*HA. To dis-
tinguish between these possibilities, we constructed wild-
type and Dire1 strains to express epitope-tagged wild-type
CPY (CPYHA) using the same vector as for CPY*HA. Ex-
pression of CPYHA caused no translocation defects in
Dire1 cells (Fig. 6 C), indicating that the defect results spe-
cifically from the expression of a misfolded protein that is
a substrate of the ERAD pathway.
In Dire1 cells expressing CPY*HA, we also observed a
translocation defect for the endogenous protein Gas1p
(Fig. 6 B, lanes 4 and 5), suggesting that the misfolded pro-
tein causes a general translocation defect in these cells. By
contrast, Dire1 cells alone or Dire1 cells expressing CPYHA
exhibit no defects in ER import of Gas1p (data not
shown). As protein import into and export from the ER
are thought to share the same translocation pore, it is pos-
sible that both processes directly compete for some limit-
ing component(s) regulated by the UPR.
Quantitative analysis of the data in Fig. 6 A showed a
delay of ER protein degradation in Dire1 cells. In wild-
type cells, 47, 13, and 3% of CPY*HA remained after 30,
60, and 90 minutes of chase, respectively. By contrast, in
Dire1 cells, 46, 37, and 22% of CPY*HA remained at the
corresponding time points. This delay could result from
two, possibly additive, effects: an impairment of import
into the ER and a delay in reexport from the ER for deg-
radation. Although the relative contributions of the two
processes to the overall delay remains to be determined,
ERAD function remains disrupted if the import block is
alleviated (see below).
Taken together, the data suggest a role of the UPR in
balancing the trafficking of proteins into and out of the
ER during periods of stress as import and export sub-
strates compete for a limiting core translocation machin-
ery. The accumulation of CPY*HA would induce the UPR
to augment the translocation machinery to clear the ER of
the misfolded proteins while maintaining protein import
into the ER. In support of this hypothesis, genes encoding
components of the translocation machinery with roles for
both import and export are targets of the UPR (Travers et
al., 2000). In addition, CPY* and CPY*HA expression each
cause UPR induction, albeit at a modest level of less than
twofold as measured by a UPRE-lacZ reporter (Knop et
al., 1996; Spear, E.D., and D.T.W. Ng, unpublished re-
sults).
To test this hypothesis, we assessed the contribution of
two specific UPR target genes by increasing their expres-
sion as it would occur during normal UPR activation. To
this end, we tested strains that contain duplicated genes
encoding Kar2p or Sec61p, respectively. These genes were
selected because of their dual roles in both ER protein im-
port and ERAD (Pilon et al., 1997; Plemper et al., 1997;
Zhou and Schekman, 1999). In addition, both genes are in-
ducible under conditions that activate the UPR (Travers
et al., 2000). As shown in Fig. 7 A, increased gene dosage
of either Kar2p or Sec61p was sufficient to alleviate the
translocation defect for preproCPY*HA and preGas1p in
Dire1 cells. Dire1 cells with increased expression of Kar2p
also alleviated the delay in CPY*HA degradation (Fig. 7, B
and C). In contrast, Dire1 cells containing an additional
copy of SEC61 remain defective in degrading CPY*HA.
The additional copy of SEC61 itself is not inhibitory to
ERAD since wild-type cells under the same circumstances
show normal if slightly accelerated ERAD function (Spear,
E.D., and D.T.W. Ng, unpublished results). These results
show that Kar2p becomes limiting for both translocation
Figure 7. Increased gene dosage of specific UPR targets alleviate
translocation and ERAD defects in UPR-deficient cells. A, Wild-
type and Dire1 cells expressing CPY*HA were pulse-labeled with
[35S]methionine/cysteine followed by immunoprecipitation for
CPY*HA (top) and Gas1p (bottom). Haploid strains DNY563
(wild-type), ESY157 (Dire1), ESY158 (ESY157 with an extra
copy of KAR2 on the centromeric plasmid pMR713; labeled
Dire1, 2n KAR2), and ESY159 (ESY157 with and extra copy of
SEC61 on the centromeric plasmid pCS15; labeled Dire1, 2n
SEC61) were analyzed. The lumenal and nontranslocated forms
(pre) are indicated. B, DNY563 (wild-type), ESY158 (Dire1, 2n
KAR2), and ESY159 (Dire1, 2n SEC61) cells were pulse-labeled
with [35S]methionine/cysteine for 10 min, followed by a cold
chase for the times indicated, CPY*HA immunoprecipitated from
detergent lysates, and separated by SDS-PAGE. C, Quantifica-
tion of immunoprecipitated CPY*HA shown in B by PhosphorIm-
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and ERAD when cells are challenged with CPY*HA, whereas
Sec61p becomes limiting only for translocation, but not
ERAD. Moreover, increased expression of either Kar2p
or Sec61p can compensate for the translocation defect in
Dire1 cells. Taken together, these data demonstrate an im-
portant role for the UPR in regulating the import and ex-
port functions across the ER membrane.
The UPR Controls a Wide Variety of ER Functions 
As described so far, the genetic approach has revealed two
new functions, ERAD and glycosylation, that, when limit-
ing, require activation of the unfolded protein response for
cell viability. In addition, cloning of per13 and per2 re-
vealed that the mutations map to GPI10 and MCD4, re-
spectively, both encoding essential components in GPI an-
chor addition. As MCD4, other genes required for GPI
biosynthesis, including GAA1, GPI12, and LAS21 are also
regulated by the UPR (Travers et al., 2000); GPI10, in
contrast, was not identified as a UPR transcriptional target
gene. Finally, cloning of per4 revealed that the mutation
resides in LHS1/SSI1, an hsp70-like ER chaperone (Bax-
ter et al., 1996; Craven et al., 1996), thus adding to the list
of classical UPR targets that mediate protein folding di-
rectly. Consistent with previous observations, the per4 mu-
tants display a minor protein translocation defect follow-
ing a short pulse label (data not shown). Thus, genetic
analysis reveals a wide variety of ER functions that are
physiologically linked to the UPR.
Discussion
Characterization of the per mutants revealed that cells re-
quire a functional UPR to cope with and compensate for
defects in many aspects of protein maturation in the ER,
including protein folding, glycosylation, and GPI anchor
addition. In addition, we found that ERAD, required to
clear the ER of unwanted proteins, is intimately linked to
the UPR. A gene expression chip analysis performed in a
parallel study to determine the transcriptional scope of the
UPR revealed that over 350 genes are transcriptionally
upregulated upon induction of the pathway (Travers et al.,
2000). Many of the identified genes function in various as-
pects of the secretory pathway at the level of the ER or be-
yond. Thus, together the results of the two studies show
that the role of the UPR is multifaceted and much more
complex than previously appreciated. Importantly, not all
of the genes identified as per mutants are transcriptional
targets of the UPR. Genetic and gene expression array
analyses therefore proved complementary rather than re-
dundant approaches, with both avenues allowing the iden-
tification of novel genes that function in these processes.
Regulation of Protein Glycosylation
Isolation of the per5-1 mutant led to the discovery of a
new gene involved in protein glycosylation. We found that
PER5 is upregulated by the UPR. PER5/RFT1 was origi-
nally cloned from a yeast mutant requiring the overex-
pressing of human p53 for viability (Koerte et al., 1995); as
there is no yeast equivalent to mammalian p53, the reason
for this phenotype and the function of PER5/RFT1 has
remained obscure. Our studies demonstrate that PER5/
RFT1 is required for efficient N-linked glycosylation of
glycoproteins.  PER5/RFT1 encodes a multispanning trans-
membrane protein that bears no significant sequence simi-
larity to any other known component of the glycosylation
machinery. Our results suggest that PER5/RFT1 functions
in biosynthesis of the dolichol-linked carbohydrate precur-
sor or in the protein conjugation step. Preliminary experi-
ments indicate that per5-1 cells show an accumulation of a
biosynthetic intermediate (Dol-PP-GlcNAc2-Man5) and a
sharp decrease in the mature form (Dol-PP-GlcNAc2-
Man9-Glc3; J. Helenius, D.T.W. Ng, P. Walter, and M. Aebi,
unpublished results). These results suggest the intriguing
possibility that PER5/RFT1 may encode the long sought-
after flippase that translocates the Dol-PP-GlcNAc2-Man5
intermediate (which is synthesized on the cytosolic face of
the membrane) to the lumenal face for further processing
(Burda and Aebi, 1999). Consistent with this view, those
carbohydrates that are attached to proteins in per5-1 cells
were found to be fully mature. Further experiments to ad-
dress this notion are in progress.
Genome expression data has shown that additional
components of the glycosylation biosynthetic machinery
are regulated by the UPR (Travers et al., 2000). The regu-
lation of glycosylation components helps cement our
broadened view of the UPR, as it indicates a role of the
pathway in adjusting the cell’s biosynthetic capacity of the
ER according to need. Similarly, we isolated per mutants
defective in GPI anchorage, and many GPI biosynthetic
genes are UPR targets (Travers et al., 2000).
UPR Regulation of ER Quality Control
The identification of ERAD genes suggested a tight physi-
ological link between ERAD and the UPR. We have pro-
vided direct evidence for such a link using CPY*HA, which
is stabilized in UPR-deficient cells. Consistent with previ-
ous studies (Kawahara et al., 1997; Zhou and Schekman,
1999), we show that various ERAD-deficient mutants con-
stitutively induce the UPR. As shown in the parallel study,
most known ERAD genes are activated by the UPR
(Travers et al., 2000). Moreover, in this study we have
shown that UPR induction increases ERAD efficiency.
Thus the UPR and ERAD are intimately coordinated and
interdependent.
The identification of SON1 (PER8) as a gene required
for ERAD provided an unexpected twist to the outcome
of our genetic screen. SON1 (also called RPN4) was re-
cently shown to be a transcriptional activator that binds a
consensus promoter element, termed PACE (Mannhaupt
et al., 1999). The PACE motif is found in many genes, but
is a common element in the family of genes encoding sub-
units of the 26S proteasome. In son1 null mutants, the deg-
radation of some cytosolic proteins are impaired at a step
following ubiquitin conjugation (Johnson et al., 1995). To-
gether, these data suggest SON1 regulates aspects of pro-
teasome biogenesis, which in turn is required for ERAD.
Surprisingly however, neither SON1 nor proteasomal sub-
unit genes are regulated by the UPR (Travers et al., 2000).
Rather, proteasomal subunit genes are coordinately up-
regulated in UPR-deficient cells following treatment with
tunicamycin or DTT (Travers et al., 2000). These results
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ER ® nucleus signal transduction pathway exists in which
Son1p may play an important role. Interestingly, the UPR
target genes PDI1 and PER5/RFT1 contain consensus
PACE promoter elements (Mannhaupt et al., 1999), and
may hence be regulated by Son1p, in addition to Hac1p.
Regulation of Protein Translocation Into and Out of
the ER
The observation that UPR-deficient cells expressing
CPY*HA exhibit general protein translocation defects re-
vealed another unexpected role for the UPR. As discussed
above, our analyses show a delay in the degradation of
CPY*HA via ERAD. We consider it likely that these two
phenomena are linked as several components of the ER
translocon are thought to be both required protein import
and export (Wiertz et al., 1996; Pilon et al., 1997; Plemper
et al., 1997): UPR-regulated factors shared between
import and export may become limiting under conditions
as an extra load of an ERAD substrate needs to be at-
tended to.
We confirmed this notion by testing two UPR target
genes with known roles in translocation for import and ex-
port by increasing their gene dosage. We found that an ex-
tra copy of SEC61 was sufficient to alleviate the import
defect, but degradation was still compromised (Fig. 7),
while an extra copy of KAR2 restored both import and
ERAD functions. These results suggest that primarily
Kar2p becomes limiting under these conditions. Interest-
ingly, expression of the mouse major histocompatability
complex class I heavy chain H-2Kb in yeast also displayed
rapid ER degradation that is dependent on UPR function
(Casagrande et al., 2000). In apparent contrast to our re-
sults, Kar2p overexpression showed no improvement of
heavy chain degradation in Dire1 cells. We also observed,
however, that more dramatic overexpression of Kar2p can
actually inhibit the degradation of CPY*HA in wild-type
cells (Spear, E.D., and D.T.W. Ng, unpublished results; J.
Brodsky, personal communication). Taken together, these
data suggest that a precise and balanced modulation of
UPR targets is required for optimal ERAD activity.
These results serve to illustrate a simple approach that
possibly can be more broadly exploited to study pathways
under UPR control. Starting with a UPR-deficient strain,
one imposes a specific nonlethal stress that in wild-type
cells would elicit a moderate UPR induction (in this case,
moderate CPY*HA expression). With the UPR off, key
components become limiting. As defects are detected, it
becomes possible to test the contribution of specific UPR
target genes by increasing their gene dosage. Only some of
many genes required for any given function are regulated
by the UPR (Travers et al., 2000) which, we surmise, are
likely to comprise those components that are rate limiting
under uninduced conditions. Thus, the approach may al-
low to identify key regulatory components even for pro-
cesses that require the contribution of multiple genes.
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